Switch to:
More From Other Websites
Former Teva CEO's new gig at Ovid Therapeutics Apr 16 2015
Amgen Announces New Data from Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study in Patients... Dec 07 2014
Amgen and Onyx Announce Detailed Results from Phase 3 ASPIRE Study of Kyprolis® (carfilzomib) in... Dec 06 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership